Qube Research & Technologies LTD Nanobiotix S.A. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.16 - $7.31 $1,148 - $2,017	-276 Reduced 44.59%	343 $1,000
Q1 2024 May 14, 2024	BUY	$6.12 - $8.13 $1,689 - $2,243	276 Added 80.47%	619 $4,000
Q4 2023 Feb 13, 2024	SELL	$5.34 - $9.19 $1,906 - $3,280	-357 Reduced 51.0%	343 $2,000
Q3 2023 Nov 13, 2023	BUY	$5.03 - $10.76 $3,521 - $7,532	700 New	700 $6,000

6.43M

Ticker NBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,875,900
Market Cap $123M
Description
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.